Mostrando 6 resultados de: 6
Filtros aplicados
Publisher
American Journal of Therapeutics(2)
Revista Latinoamericana de Hipertension(2)
Current Pharmaceutical Design(1)
F1000Research(1)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(3)
Fisiología humana(2)
Medicina y salud(2)
Bioquímica(1)
Área de conocimiento
Enfermedad cardiovascular(3)
Medicina interna(3)
Farmacología(2)
Epidemiología(1)
Genética(1)
Dyslipidemia: Genetics, lipoprotein lipase and hindiii polymorphism
ReviewAbstract: The direct link between lipid metabolism alterations and the increase of cardiovascular risk are welPalabras claves:Coronary artery disease, dyslipidemia, HindIII, Lipoprotein Lipase, polymorphismsAutores:Cano-Ponce C., Carem Prieto, D’Addosio R., Garicano C.M.D., Hoedebecke K., Martínez M.S., Martínez N.G., Nava T.N., Parra S.M., Pérez A., Rojas E.R., Rojas M.P., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Vicuña P.M.Fuentes:scopusPrevalence of different lipid profile abnormalities in the consultation of cardiovascular risk factors from the "Dr. Félix Gómez" Endocrine and Metabolic Diseases Research Center in the period from January 2006 to January 2007
ArticleAbstract: Objective: Isolated (or mixed with other dyslipidemias) low HDLc levels are risk factors for coronarPalabras claves:Cardiovascular disease, dyslipidemia, Low isolated HDLc, PREVALENCEAutores:Cano-Ponce C., Luti Y., Mengual-Moreno E., Sánchez D., Scott G., Valmore Bermúdez, Velasco M.Fuentes:scopusPharmacologic management of isolated low high-density lipoprotein syndrome
ArticleAbstract: High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a varPalabras claves:atherosclerosis, cholesterol, Coronary artery disease, dyslipidemia, HDLc, Reverse cholesterol transportAutores:Acosta L., Amell A., Arráiz N., Bermúdez F.A., Cano R.A., Cano-Ponce C., Finol F., Hernández-Hernandez R., Hidalgo J., Kendall P., Manuel V., Pabón M.R., Reyna-Villasmil N., Valmore BermúdezFuentes:scopusPhytotherapy for cardiovascular disease: A bench-to-bedside approach
ReviewAbstract: At present, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality world-Palabras claves:atherosclerosis, Cardiovascular disease, dyslipidemia, Hypertension, Medicinal herbs, PhytotherapyAutores:Cano-Ponce C., Chávez-Castillo M., Durán P., González M.C., Marquina M., Ortega A., Pírela D., Rojas-Quintero J., Salazar-Vílchez J., Valmore Bermúdez, Velasco M.Fuentes:scopusSerum lipoprotein (a) in patients post myocardial infarction
ArticleAbstract: Lipoprotein (a) [Lp (a)] is considered an independent risk factor for cardiovascular disease. In ourPalabras claves:Abdominal circumference, body mass index, dyslipidemia, Lipoprotein (a), myocardial infarctionAutores:Amell A., Añez-Ramos R., Arráiz N., Cano-Ponce C., Carem Prieto, Carrillo M., Cruz S., González M.C., Joselyn Zula, Montiel M., Salazar-Vílchez J., Silva C., Toledo A.C., Torres Y., Valmore Bermúdez, Vergara P.M.Fuentes:googlescopusThe maracaibo city metabolic syndrome prevalence study: Design and scope
ArticleAbstract: The metabolic syndrome (MS) is a conglomerate of interrelated risk factors-including obesity, atheroPalabras claves:Blood pressure, Cardiovascular Risk Factors, cross-sectional studies, dyslipidemia, Metabolic syndromeAutores:Amell A., Arráiz N., Cabrera M., Cano J.R., Cano R.A., Cano-Ponce C., Finol F., González J., Luti Y., Marcano R.P., Mengual-Moreno E., Miranda J.L., Montes J., Reyna-Villasmil N., Rojas E.R., Sánchez D., Sanchez W., Valmore Bermúdez, Vega L., Velasco M.Fuentes:scopus